Li Q, Yang G, Zheng J, Xu J, Zhou X
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), National Health Commission Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai 200025, China.
School of Tropical Medicine, Hainan Medical University, China.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2023 Mar 2;35(1):1-6. doi: 10.16250/j.32.1374.2023016.
Following concerted efforts for over 7 decades, great achievements have been gained in the national schistosomiasis control program of China. Currently, China is moving towards the stage of schistosomiasis elimination, when the major task is to make full use of available resources to improve schistosomiasis surveillance and response to sustainably consolidate gained schistosomiasis control achievements and prevent re-emerging schistosomiasis. There is therefore an urgent need for optimization of interventions for schistosomiasis elimination. Based on analysis of socioeconomic features at different stages of the national schistosomiasis control program in China, this review discusses the relationship between the needs of assessment of schistosomiasis elimination interventions and the optimized strategy of schistosomiasis elimination at different stages of the national schistosomiasis control program using a marginal benefit approach and proposes the optimized schistosomiasis elimination strategy that allows the highest marginal benefit with currently available schistosomiasis elimination costs, so as to provide the optimal strategic pathway to schistosomiasis elimination and facilitate the achievement of the targets set in Healthy China 2030.
经过70多年的共同努力,中国的国家血吸虫病防治项目取得了巨大成就。目前,中国正迈向血吸虫病消除阶段,此时的主要任务是充分利用现有资源,加强血吸虫病监测和应对,以可持续地巩固已取得的血吸虫病防治成果,并防止血吸虫病再度流行。因此,迫切需要优化血吸虫病消除干预措施。基于对中国国家血吸虫病防治项目不同阶段社会经济特征的分析,本综述采用边际效益方法,探讨了血吸虫病消除干预措施评估需求与国家血吸虫病防治项目不同阶段血吸虫病消除优化策略之间的关系,并提出了在当前可用的血吸虫病消除成本下能实现最高边际效益的优化血吸虫病消除策略,从而为实现血吸虫病消除提供最佳战略途径,并推动实现《健康中国2030规划纲要》设定的目标。